Insilico Medicine lists on the Hong Kong Stock Exchange
Insilico Medicine listed on the Hong Kong Stock Exchange on 30 December 2025 under code 3696.HK, raising HKD 2.277 billion in what it called the largest Hong Kong biotech IPO of 2025 by funds raised.